compounded tirzepatide no longer available Important Update: Phasing Out! Eli Lilly just issued a

That's not the trade high-performing executives should make

A shelf-stable GLP-1 probiotic that actually reaches the intestine supports GI balance during treatment.*

Our Scientific Affairs team made the trip to New Orleans for the #ADASciSessions, where we presented new real-world GLP-1 research, including: Better Sleep, More Energy, and Less Daytime Sleepiness on Ro: evaluating sleep apnea outcomes among patients treated with tirzepatide on Ro

Reports of Ozempic mouth gum inflammation, tooth decay, and bad breath are emerging among people using GLP-1 drugs.

This review summarizes recent advances in the clinical applications of glucagon-like peptide-1 receptor agonists (GLP-1RAs) beyond their established role in glycemic control for type 2 diabetes (T2DM)

Evidence Rating Level: 1 (Excellent) Study Rundown: There is strong overlap between weight gain and type 2 diabetes, with the majority of diabetic patients being overweight or